SEC Tracker
Get the app

Akebia Therapeutics AKBA

Akebia Therapeutics, Inc. entered into a lease agreement with BP THIRD AVENUE LLC

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Takes on a new financial obligation (2.03)
  • Reports an executive or board change (5.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Akebia Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Viridian Therapeutics VRDN public float $943M, Jun 30, 2025
  2. Collegium Pharmaceutical COLL public float $926M, Jun 30, 2025
  3. Ardelyx ARDX public float $924M, Jun 30, 2025
  4. Neogen NEOG public float $972M, Nov 30, 2025
  5. CorMedix CRMD public float $910M, Jun 30, 2025